Envase
Envase
INHIBIDORES NOVEDOSOS.
13/07/2022 -
The invention relates to a compound of formula (I): A-B-D-E (I) or a pharmaceutically acceptable salt, solvate or polymorph thereof, including all tautomers and stereoisomers thereof, wherein: A...
RXR AGONIST SALT FORMS, POLYMORPHS THEREOF, AND USES THEREOF
21/09/2023 -
Provided herein are salt and solid forms of (2E,4E)-3-methyl-5-((1S,2S)-2-methyl-2-(5, 5, 8, 8-tetramethyl-5, 6, 7,8- tetrahydronaphthalen-2-yl)cyclopropyl)penta-2,4-dienoic acid, and polymorphs...
NANOENCAPSULATED PHARMACEUTICAL COMPOSITION AND USE THEREOF
21/09/2023 -
This disclosure is directed to a pharmaceutical composition for treating or preventing a disease. The pharmaceutical composition can comprise a polymer-drug nanoaggregate having a polymer and at...
PROCESSES FOR PREPARATION OF CABOTEGRAVIR OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
21/09/2023 -
The present invention generally relates to processes for preparation and purification of cabotegravir and its intermediate thereof. The present invention further relates to a process for...
COMPOSICIONES Y METODOS DE USO DE 2-(4-CLOROFENIL)-N-((2-(2,6-DIOX OPIPERIDIN-3-IL)-1-OXOISOINDOLIN-5-IL)METIL)-2,2-DIFLUOROACETAMID A.
09/06/2022 -
Provided herein are formulations and methods of use of 2-(4-chlorophenyl)-N-((2-(2,6- dioxopiperidin-3-yl)-l-oxoisoindolin-5-yl)methyl)-2,2-difluoroa cetamide or a stereoisomer or mixture of...
METODO PARA TRATAR A UN NI?O CON PUBERTAD PRECOZ CENTRAL USANDO UNA COMPOSICION DE LIBERACION PROLONGADA.
08/06/2022 -
An extended release formulation is provided for use in a method for the treatment of Central Precocious Puberty (CPP) in pediatric patients 2 years of age or older. The extended release...
COMPUESTOS DE PIRAZOL, FORMULACIONES DE LOS MISMOS Y UN METODO PARA USAR LOS COMPUESTOS Y/O FORMULACIONES.
02/06/2022 -
Disclosed herein are embodiments of a pyrazole compound according to formula (I). Compositions comprising the compound, and a method for making the composition also are disclosed. The composition...
POLIMEROS ENLAZADOS AL PROTON PARA ADMINISTRACION ORAL.
02/06/2022 -
Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers...
PROCESO PARA LA SINTESIS DE NANOPARTICULAS DE OXIDO DE ZINC EMPELANDO EXTRACTO DE DESECHOS MARINOS DE SARGAZO.
01/06/2022 -
The present invention aims to provide a novel process in which sargassum waste is collected on beaches and stored for up to five years, used for synthesizing zinc oxide nanoparticles (NP-ZnO) with...
PROCESO PARA LA SINTESIS DE NANOPARTICULAS DE OXIDO DE ZINC EMPELANDO EXTRACTO DE DESECHOS MARINOS DE SARGAZO.
01/06/2022 -
The present invention aims to provide a novel process in which sargassum waste is collected on beaches and stored for up to five years, used for synthesizing zinc oxide nanoparticles (NP-ZnO) with...
TRIGGER ASSEMBLY FOR ATOMIZER AND ATOMIZER
14/09/2023 -
A trigger assembly for an atomizer, the trigger assembly comprising a trigger ring (1000) and a delivery tube base (2000), wherein the trigger assembly has a locked position and an unlocked...
VITAMIN AD ORALLY DISSOLVING FILM COMPOSITION AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
14/09/2023 -
Provided are a vitamin AD orally dissolving film composition and a preparation method therefor and an application thereof. The vitamin AD orally dissolving film composition contains an active drug...
VITAMIN AD ORALLY DISSOLVING FILM COMPOSITION AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
14/09/2023 -
Provided are a vitamin AD orally dissolving film composition and a preparation method therefor and an application thereof. The vitamin AD orally dissolving film composition contains an active drug...
FORMULACIONES DE APREMILAST
30/08/2023 -
En el presente documento se proporcionan formas farmacéuticas orales que comprenden a) un núcleo del comprimido que comprende (i) una capa de fármaco que comprende apremilast y acetato...
Triazolopyridine polymorph A
05/09/2023 -
The invention relates to a Form A polymorph of a triazolopyridine compound, pharmaceutical compositions and methods of use thereof.
Composiciones farmacéuticas de pralsetinib
14/07/2023 -
La presente descripción se refiere a una composición farmacéutica que comprende 1) una dispersión sólida amorfa que comprende pralsetinib, o una sal farmacéuticamente aceptable de este; y un...
COMPOSICION Y METODOS PARA EL TRATAMIENTO DE TRASTORNOS ANALES Y RECTALES.
22/02/2022 -
The present invention relates to compounds or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers, prodrugs, hydrates and or derivatives thereof. The Pharmaceutical...
POLIMORFOS DE VORUCICLIB Y METODOS DE ELABORACION Y USO DE LOS MISMOS.
11/03/2022 -
The disclosure relates to crystalline solid forms of voruciclib, including voruciclib free base and various voruciclib salts, pharmaceutical compositions containing voruciclib crystalline solid...
FORMULACIONES DE LIBERACION MODIFICADA DE 2-[3-[4-AMINO-3-(2-FLUOR O-4-FENOXI-FENIL)PIRAZOLO[3,4-D]PIRIMIDIN-1-IL]PIPERIDINA-1-CARBO NIL]-4-METIL-4-[4-(OXETAN-3-IL)PIPERAZIN-1-IL]PENT-2-ENENITRILO.
06/04/2022 -
Modified release formulations, such as solid oral dosage forms comprising a core composition comprising Compound (I) and/or a pharmaceutically acceptable salt thereof; a sub-coating layer coating...
PHARMACEUTICAL COMPOSITIONS FOR HEMOSTASIS AND WOUND HEALING IN GASTROINTESTINAL TRACT
24/08/2023 -
Provided are a pharmaceutical composition for hemostasis in the gastrointestinal tract and a pharmaceutical composition for wound healing in the gastrointestinal tract. The pharmaceutical...
